Written in Blood

Written in Blood

Research from recent issues of Blood

WIB_icon

Outcomes with Azacitidine Similar to Other Treatments for Older Patients with AML

Older patients with acute myeloid leukemia (AML) may benefit similarly from treatment with the hypomethylating agent azacitidine as they do to other chemotherapy approaches,...
WIB_icon

Race-Specific Dosing Guidelines Urged for Warfarin

Since the National Institutes of Health issued a call for broader racial representation in clinical research, clinicians and researchers have met that challenge with...
WIB_icon

Cord Blood Cell Fucosylation Bolsters Transplant Capabilities

Although cord blood transplantation (CBT) is a viable alternative for patients lacking an HLA-matched donor, using cord blood as a source of stem cells...
WIB_icon

HCT Remains Best Bet for High-Risk Primary Myelofibrosis

Physicians treating patients with primary myelofibrosis have one curative treatment option: hematopoietic cell transplantation (HCT). The procedure, can be associated with significant morbidity and...
WIB_icon

Similar Outcomes with Different Daunorubicin Doses in AML

The combination of cytosine arabinoside (Ara-C) and an anthracycline has held its ground as the standard induction therapy for acute myeloid leukemia (AML) for more...
WIB_icon

Gene Therapy Proves Promising for Children with “Bubble Boy” Disease

Treatment of X-linked severe combined immunodeficiency (SCID-X1), a rare immune disorder also known as “bubble boy disease,” often involves stem cell transplantation from a...
WIB_icon

Childhood ALL Survivors Struggle with Obesity and Long-Term Fitness Deficits

In the past few decades, treatment of childhood acute lymphoblastic leukemia (ALL) has been recognized as one of the true success stories in hematologic...
WIB_icon

Entospletinib Makes Its Mark in Chronic Lymphocytic Lymphoma

Therapies that target B-cell receptor signaling kinases have made great strides in chronic lymphocytic lymphoma (CLL) and other B-cell malignancies. According to results from...
WIB_icon

How Can We Better Predict High-Risk Pregnancies for Women with SCD?

Though sickle cell disease (SCD) is associated with significant lifetime morbidity and premature mortality, better quality of care has led to improved survival, with...
WIB_icon

Novel Agent Attacks the Cause of Vaso-Occlusive Crisis in Sickle Cell Disease

Vaso-occlusive crisis (VOC) is a severely painful disease manifestation in adolescent and adult patients with sickle cell disease (SCD). Currently, treatment is limited to...
Advertisement

Current Issue

May 2020, Volume 6, Issue 6

This issue discusses AI's potential to improve patient care, debates using donors with clonal hematopoiesis for alloHCT, and more.